Background: To date, 13 different neurofilament lightchain polypeptide gene (NEFL) mutations have been iden-tifiedin55patientswithCharcot-Marie-Toothdisease(CMT) from 16 families. NEFL mutations were found to be associated with axonal and demyelinating variants of CMT.Objectives: To describe the clinical features of 11 patients with CMT and NEFL mutations and to explore possible genotype-phenotype correlations.Design: Standardized neuromuscular and nerve conduction studies were performed, and the coding regions of the peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ), gap junction -1 protein (GJB1), and NEFL genes were analyzed by direct DNA sequencing.Setting: Two university hospitals in Austria (referral centers for neuromuscular disorders).Patients: Eleven patients with CMT and NEFL mutations.Main Outcome Measure: We genotyped NEFL in all of the patients and healthy relatives and correlated the genotype with the phenotype.Results: A novel NEFL mutation (p.L93P) was detected in 1 family with 4 affected individuals exhibiting a severe CMT phenotype. Nerve conduction velocities were intermediately slowed to a range of 35 to 39 m/s. In a second family and in a sporadic patient, a p.P8R mutation was identified with intermediate and severe nerve conduction slowing.
Conclusion:The results argue against an obvious genotype-phenotype correlation regarding disease onset, degree of muscle weakness, and nerve conduction slowing caused by NEFL mutations.